Times Online
4 Aug 2008
Leo Lewis, Asia Business Correspondent
TauRx Therapeutics, an almost unknown drugs company, has found itself at the centre of worldwide attention after details of its Rember drug for Alzheimer's disease were released last week.
Global drugs giants are beating a path to TauRx's door and, if the Rember drug fulfils its early promise, it could help to catapult Singapore on to the global biotechnology map.
>>>> More
